Navigation Links
Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology

in this press release include the possibility of being unable to obtain regulatory approval of the Company's product candidates, the risk that the results of clinical trials may not support the Company's claims, and risks related to the Company's ability to protect its intellectual property and its reliance on third parties to develop its product candidates. The Company assumes no obligation to update these forward-looking statements, except as required by law.

ZIOP-G

Contact

ZIOPHARM Oncology, Inc.
Investors
Suzanne McKenna, 646-214-0703
smckenna@ziopharm.com
or
Media
Tina Posterli, 917-322-2565
tposterli@rxir.com


'"/>




Page: 1 2 3

Related medicine technology :

1. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Protox Announces Positive Clinical Data from Prostate Cancer Study
5. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
6. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
7. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
8. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
9. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
10. Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis
11. Alkermes Announces Positive Results from Phase 1/2 Clinical Study of ALKS 29
Post Your Comments:
(Date:5/19/2008)...cs present preliminary Phase II data for the...d mechanically-ventilated patie...Call/ -- Bayer HealthCare,together with Nektar The...ve,preliminary Phase II data on their unique drug-... Thoracic Society (ATS) annual meeting. Amikacin,I...
(Date:5/19/2008)...Replacement Structurally Similar to, Native Bladde...iefing and Poster Sess... /- Tengion,Inc., a clinical stage b...,neo-organs and neo-vessels, presented preclinical...ment(TM) at the Annual Meeting of the American,Uro...
(Date:5/19/2008)...e 2008 Annual European Congress of, Rheumatology O... (EULAR) -, - Initiation of Phase 1 Human Study o... 2008 -, SAN DIEGO, May 19 /PRNe...aq: RDEA ) today announced the identification of ...f patients with gout, RDEA594. Gout is a,painful a...
(Date:5/19/2008)...t Scientists Refused To Do,Illustrates Vaccine Pro...TLANTA, May 19 /PRNewswire-USNewswire/ -- Findings...vaccines officially recommended by the CDC,and the...tism-like,symptoms. Lead investigator Laura Hewits...presented study results at the International Meeti...
Breaking Medicine Technology:Amikacin Inhale Shows Promising Results in Phase II Study 2Amikacin Inhale Shows Promising Results in Phase II Study 3Amikacin Inhale Shows Promising Results in Phase II Study 4Amikacin Inhale Shows Promising Results in Phase II Study 5Amikacin Inhale Shows Promising Results in Phase II Study 6Amikacin Inhale Shows Promising Results in Phase II Study 7Preclinical Data Demonstrate Ability to Regenerate an Entire Bladder With Tengion Neo-Bladder Replacement(TM) 2Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594 2Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594 3Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594 4Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594 5Infant Vaccines Produce Autism Symptoms in New Primate Study by University of Pittsburgh Scientists 2Fossil record supports evidence of impending mass extinction 935 1Fossil record supports evidence of impending mass extinction 935 2Yale chemist receives NIH Young Investigator Award for antibody targeting 934 1Yale chemist receives NIH Young Investigator Award for antibody targeting 934 2Yale chemist receives NIH Young Investigator Award for antibody targeting 934 3The Salvation Army Responds to Immediate Needs of Survivors and Relief Workers in Southern California Wildfires 4443 1The Salvation Army Responds to Immediate Needs of Survivors and Relief Workers in Southern California Wildfires 4443 2The Salvation Army Responds to Immediate Needs of Survivors and Relief Workers in Southern California Wildfires 4443 3ACC Concerned Over Reporting of Biomonitoring Results 625 1ACC Concerned Over Reporting of Biomonitoring Results 625 2ACC Concerned Over Reporting of Biomonitoring Results 625 3
...SS WIRE)--Jul 2, 2007 - ViaCell, Inc.,(NASDAQ: VIA...d,Chief Executive Officer of ViaCell, will present...pipeline at the C.E. Unterberg,Towbin Emerging Gr... 2007 at 3:00 p.m. at the Mandarin Oriental Hotel ...ntation will be available on,the Investor Informat...
...0, 2007 /PRNewswire-FirstCall/ - Bradmer,Pharmaceu... to the,development and commercialization of cance...lished by an independent team in,Basel, Switzerlan...get for the development of new treatments for glio...ified that the loss of NOTCH2 gene,positively pred...
Other Medicine Technology:Molecular Target of Bradmer's Neuradiab Further Validated by,Independent Findings 2Molecular Target of Bradmer's Neuradiab Further Validated by,Independent Findings 3Molecular Target of Bradmer's Neuradiab Further Validated by,Independent Findings 4
(Date:5/20/2008)...e/ -- Ambulatory Services of,America, Inc. announc...h,joint venture to provide outpatient radiation on... between Denton Cancer Center, LP and ASA,s,subsid... ROSA of Denton,will own and operate a radiation t...ly owned and operated by Denton Cancer Center., (...
(Date:5/20/2008)...ng new out-patient procedures at no ... Calif., May 20 /PRNewswire/ -- Compass Clinical R... San Francisco Bay Area (RSC) are,hoping to recrui...nx, a,build-up of fluid in the fallopian tubes tha... as a part of a study of the effectiveness of a ne...
(Date:5/20/2008)...turated Fat - and with Omega-3, PARAMUS, N.J., Ma...(Nasdaq: SMBL ) has launched Smart Balance(R) But...utter Blend Sticks are 50 percent real butter,and ...art Balance(R) Butter,Blend Sticks are offered in ...or a healthier and tasty alternative for use in co...
(Date:5/20/2008)...ery or survival, researchers say. , , T...y dialysis for patients with acute kidney injury d...reduce the rate of organ failure, a new study find...n seen in critically ill patients. Approximately 2...d 35 percent of critically ill patients, will suff...
Breaking Medicine News(10 mins):Health News:Ambulatory Services of America, Inc. Announces Joint Venture With Denton Cancer Center, LP 2Health News:Research Grant to Fund Free Surgeries for Women Suffering From Blocked Fallopian Tubes 2Health News:Research Grant to Fund Free Surgeries for Women Suffering From Blocked Fallopian Tubes 3Health News:New Smart Balance(R) Butter Blend Sticks Make Healthier Cooking & Baking Easy 2Health News:More Dialysis Not Better in Acute Kidney Injury 2
...gnal is thought to worsen the symptoms of MS, say ...ach that holds promise in the development of novel...sease, for which a concrete cure is not yet in pla...xercise to effectively impede the protein that is ...
...s of surgery to separate four-year-old conjoined t... intestines and pelvis and are working// to separa...s billed as the first to try to separate twins who...d Maliyah Herrin are joined at mid-torso and also ...
... hundreds of thousands displaced by the Israel-Hez...towards severe shortages of fuel// and drinking wa...faced with a major setback - and with the fuel pro...owards a de-facto blockade of the country," said a...
... and Drug Administration's decision on whether to ...en before the scientists submitted their recommend... sworn statements before court. Dr. John Jenkins,...rugs, said in a sworn statement in June that he wa...
Other Medicine News:Health News:Lebanon Fears of Epidemics as the Crisis Deepens 2
Stainless steel threaded Steinman Pins available in point types A,D, E, and F.
Swanson Finger Pins are stainless steel and available in one length and three diameters.
Instera pins are sterile packaged and are available in 0.89, 1.1, 1.5, and 2.0mm diameters.
...ng Jet-X Pin products are available: , 5mm x 30mm ...6 Cannulated H-Pin , 5mm x 50mm Traction Pin ...SST Half Pin , TI 5mm Half Pin , TI 5mm x ...in , TI Half Pin , TiN 5 x 40, 1.6 Cann ...
Medicine Products: